289 related articles for article (PubMed ID: 21252099)
1. Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents.
Fritz G; Henninger C; Huelsenbeck J
Br Med Bull; 2011; 97():17-26. PubMed ID: 21252099
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo.
Ostrau C; Hülsenbeck J; Herzog M; Schad A; Torzewski M; Lackner KJ; Fritz G
Radiother Oncol; 2009 Sep; 92(3):492-9. PubMed ID: 19615773
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
Fritz G
Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.
Nübel T; Damrot J; Roos WP; Kaina B; Fritz G
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):933-9. PubMed ID: 16467108
[TBL] [Abstract][Full Text] [Related]
5. Potential antitumor effects of statins (Review).
Jakobisiak M; Golab J
Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
7. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
8. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
Katz MS
Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
[TBL] [Abstract][Full Text] [Related]
9. [Anti-inflammatory effect of HMG-CoA reductase inhibitors].
Kitamoto S; Egashira K
Nihon Rinsho; 2004 Jan; 62(1):172-9. PubMed ID: 14737850
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
Tristano AG; Fuller K
Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
[TBL] [Abstract][Full Text] [Related]
11. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
12. Investigating the potential neuroprotective effects of statins on DNA damage in mouse striatum.
Coetsee TN; Pretorius PJ; Terre'blanche G; Bergh JJ
Food Chem Toxicol; 2008 Sep; 46(9):3186-92. PubMed ID: 18692114
[TBL] [Abstract][Full Text] [Related]
13. Statins and their role in vascular protection.
Mason JC
Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
[TBL] [Abstract][Full Text] [Related]
14. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
Wojakowski W; Gmiński J
Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
[TBL] [Abstract][Full Text] [Related]
15. [The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance].
Rübe CE; Rodemann HP; Rübe C
Strahlenther Onkol; 2004 Sep; 180(9):541-9. PubMed ID: 15378184
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of human HMG-CoA reductase in Saccharomyces cerevisiae: a system to analyse normal and mutated versions of the enzyme in the context of statin treatment.
Wysocka-Kapcinska M; Lutyk-Nadolska J; Kiliszek M; Plochocka D; Maciag M; Leszczynska A; Rytka J; Burzynska B
J Appl Microbiol; 2009 Mar; 106(3):895-902. PubMed ID: 19187128
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
Schönbeck U; Libby P
Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
[TBL] [Abstract][Full Text] [Related]
18. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
19. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
Sawada N; Itoh H; Nakao K
Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitors of HMG CoA reductase: new modes of action, new indications?].
Essig M; Vrtovsnik F; Friedlander G
Therapie; 2000; 55(1):43-9. PubMed ID: 10860000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
